XML 30 R4.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Operating expenses:    
Research and development $ 73,278 $ 27,670
General and administrative 17,612 14,088
Total operating expenses 90,890 41,758
Loss from operations (90,890) (41,758)
Other income, net 10,286 4,809
Net loss $ (80,604) $ (36,949)
Net loss per share, basic $ (1.32) $ (0.84)
Net loss per share, diluted $ (1.32) $ (0.84)
Weighted average common shares outstanding, basic 61,256,084 43,901,241
Weighted average common shares outstanding, diluted 61,256,084 43,901,241
Comprehensive loss:    
Net loss $ (80,604) $ (36,949)
Other comprehensive loss:    
Unrealized gain on marketable securities 67 112
Total other comprehensive gain 67 112
Total comprehensive loss $ (80,537) $ (36,837)